Sirona Medical Secures $40M in Series B Funding
The investment, led by GreatPoint Ventures, will fuel the commercialization of Sirona’s platform, poised to transform radiology IT
November 9, 2021
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
The investment, led by GreatPoint Ventures, will fuel the commercialization of Sirona’s platform, poised to transform radiology IT
The oversubscribed funding was led by strategic investors from within the spine industry along with prominent and continuing investment by the Genesis Innovation Group’s cultivate(MD) Seed II Fund.
The investment further validates the potential of Gyroscope’s gene therapy GT005 for the treatment of Geographic Atrophy, one of the world’s leading causes of blindness, and supports its ongoing Phase II development programs.